Remove Bicuspid/Mitral Remove Hospital Remove Open-Heart Surgery
article thumbnail

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

DAIC

The academic medical centers received three-star ratings in isolated coronary artery bypass grafting (CABG) and isolated mitral valve replacement and repair (MVRR) surgeries. Jersey Shore University Medical Center also received a three-star rating in isolated aortic valve replacement (AVR) surgery. and Canada.

article thumbnail

Staten Island University Hospital's Cardiothoracic Program Achieves Prestigious STS Three-Star Quality Ratings

DAIC

The cardiothoracic surgery programs at four Northwell Health hospitals received this distinguished accolade, showcasing their commitment to delivering exceptional care and achieving outstanding outcomes. of participants nationally scored in this category.

article thumbnail

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

DAIC

milla1cf Mon, 06/03/2024 - 12:36 June 3, 2024 — HighLife SAS , a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe Mitral Regurgitation (MR), announced today that the U.S. I am honored to lead the HighLife pivotal study.

article thumbnail

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

DAIC

These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. an interventional cardiologist and structural heart disease expert at Henry Ford Health. “We

article thumbnail

Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease

DAIC

It is one of only two New Jersey hospitals offering the trial to patients. Many patients with symptoms of mitral regurgitation are not candidates for open heart surgery due to their advanced age or competing comorbidities, nor are they candidates for the only alternative, the MitraClip device.

article thumbnail

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. director of Interventional and Structural Heart Research at Henry Ford Hospital.

article thumbnail

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation , director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital, and co-principal investigator of the TRILUMINATE Pivotal trial.

Tricuspid 105